Major lupus drug trial halted before starting
NCT ID NCT06456567
Summary
This was a large, late-stage study designed to test whether an investigational drug called telitacicept could better control disease activity in people with moderate-to-severe lupus compared to a placebo. The drug works by targeting parts of the immune system thought to drive the disease. The study was withdrawn before any participants were enrolled.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SYSTEMIC LUPUS ERYTHEMATOSUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hemet site
Hemet, California, 92543, United States
-
Menifee site
Menifee, California, 92586, United States
-
Rockford site
Rockford, Illinois, 61114, United States
-
Stafford site
Stafford, Texas, 77477, United States
Conditions
Explore the condition pages connected to this study.